APA (7th ed.) Citation

Liang, Y., Tebaldi, T., Rejeski, K., Joshi, P., Stefani, G., Taylor, A., . . . Halene, S. (2018). SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells. Leukemia, 32(12), 2659-2671. https://doi.org/10.1038/s41375-018-0152-7

Chicago Style (17th ed.) Citation

Liang, Yang, et al. "SRSF2 Mutations Drive Oncogenesis by Activating a Global Program of Aberrant Alternative Splicing in Hematopoietic Cells." Leukemia 32, no. 12 (2018): 2659-2671. https://doi.org/10.1038/s41375-018-0152-7.

MLA (9th ed.) Citation

Liang, Yang, et al. "SRSF2 Mutations Drive Oncogenesis by Activating a Global Program of Aberrant Alternative Splicing in Hematopoietic Cells." Leukemia, vol. 32, no. 12, 2018, pp. 2659-2671, https://doi.org/10.1038/s41375-018-0152-7.